NPR News: Moderna asks FDA to authorize first COVID-19 vaccine for very young children

Moderna asks FDA to authorize first COVID-19 vaccine for very young children
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

Read more on NPR
Làm đẹp Blog 247 April 28, 2022 at 06:00PM
Category Science